The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 917-920

  Gansauge, Frank ^a,c   Ramadani, Marco ^a   Schwarz, Michael ^a   Beger, Hans G ^a   Lotspeich, Erkki ^b   Poch, Bertram ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Department of Surgery   (Germany)

^c Center for Oncological Endocrinological and Minimal access Surgery   (Germany)

Author keywords

Advanced pancreatic cancer; Cancer; Chemotherapy; Gemcitabine; NSC 631570; Pancreas

Indexed keywords

GEMCITABINE; NSC 631570; UKRAIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD DISEASE; CANCER ADJUVANT THERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONSTIPATION; DIARRHEA; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; PANCREAS CANCER; PRIORITY JOURNAL; RECURRENT DISEASE; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BERBERINE ALKALOIDS; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PHENANTHRIDINES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34250158040     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82:111-115.
2. Nitecki SS, Sarr MG, Colby TV, van Heerden JA: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221:59-66.
3. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J: Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161:120-124.
4. Baumel H, Huguier M, Manderscheid JC, Fabre JM, Houry S, Fagot H: Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery. Br J Surg 1994; 81:102-107.
5. Kawarada Y, Das BC, Naganuma T, Isaji S: Surgical treatment of pancreatic cancer. Does extended lymphadenectomy provide a better outcome? J Hepatobiliary Pancreat Surg 2001; 8:224-229.
6. Moore M: Activity of gemcitabine in patients with advanced pancreatic carcinoma. A review. Cancer 1996; 78:633-638.
7. Burris HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15:2403-2413.
8. Kurosaki I, Hatakeyama K: The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine in node-positive pancreatic cancer. Hepatogastroenterology 2004; 51:634-637.
9. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Der venis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Buchler MW: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001; 358:1576-1585.
10. Gansauge F, Ramadani M, Pressmar J, Gansauge S, Muehling B, Stecker K, Cammerer G, Leder G, Beger HG: NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial. Langenbecks Arch Surg 2002; 386:570-574.
11. Birk D, Beger HG: Lymph-node dissection in pancreatic cancer - what are the facts? Langenbecks Arch Surg 1999; 384:158-166
12. Beger HG, Rau B, Gansauge F, Poch B, Link KH: Treatment of pancreatic cancer: challenge of the facts. World J Surg 2003; 27:1075-1084.
13. Delcore R, Rodriguez FJ, Forster J, Hermreck AS, Thomas JH: Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 1996; 172:463-468.
14. Lygidakis NJ, Papadopoulou P: Pancreatic head carci noma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer? Hepatogastroenterology 1995; 42:587-596.
15. Nagakawa T, Kayahara M, Ohta T, Ueno K, Konishi I, Miyazaki I: Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer. Int J Pancreatol 1991; 10:113-119.
16. Ishikawa O: Surgical technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepatogastroenterology 1996; 43:320-325.
17. Kosuge T, Kiuchi T, Mukai K, Kakizoe T: A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. Jpn J Clin Oncol 2006; 36:159-165.